1 / 8

Health Technology Assessment

Health technology assessment concerns the various positive and negative outcomes of healthcare technology. It gives the complete interpretation about the health technology, as it helps to predict, analyze and evaluate its outcomes. The applications of this technology provide complete information of medical devices, health care services and systems, vaccines and biomedical innovations.

Panaxea
Download Presentation

Health Technology Assessment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Health Technology Assessment How to move from belief to proof? http://panaxea.eu/

  2. Want to be convinced about “value for money” before the technology enters next development stages or clinical practice. Payers have become players

  3. Scientific assessment of Health Technology • Safety and efficacy; • The future impact on clinical and other patient outcomes; • Effects on economical, social, a/o ethical aspects of care. Aim HTA: • Generate objective data of high scientific quality . • Support decision-making regarding : • Investment, • Design, (continuing) development, • Pricesetting, • Market access and reimbursement of new technologies

  4. HTA increasingly important for development of successful for medical health technologies.

  5. Advantages to be gained from HTA • Prevent investment in developing technologies that could never meet the value requirements • Support developers to prioritize between several competing concepts or prototypes • Great flexibility at early stages to design products in accordance with user preferences • Directs efficient R&D spending

  6. What does this all mean to early stage companies? • Fundamental disconnect between how companies develop evidence and what payers want to see • Easy to waste lots of cash and management time for very little in return if reimbursement is not in place or easy achievable • Be realistic about quality of your data and what you can afford to spend on additional studies

  7. HTA helps to “move from belief to proof” with a greater chance of success Conclusion

  8. Thanks For Watching

More Related